Cargando…
A rare case with fetal autoimmune heart block and KNCH2 variant–induced long QT syndrome: a controversial opinion on prenatal management strategy
BACKGROUND: Among all fetal heart block patients, > 50% cases are associated with maternal autoimmune diseases, and such patients should receive treatment. However, nearly half of fetal heart block cases involve a mother with negative results following autoimmune antibody screening. A few studies...
Autores principales: | Wei, Li, Wu, Jiahao, Xie, Peihuan, Liu, Xiaoliang, Hua, Yimin, Zhou, Kaiyu, Wang, Chuan, Li, Yifei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044358/ https://www.ncbi.nlm.nih.gov/pubmed/36973673 http://dx.doi.org/10.1186/s12872-023-03198-8 |
Ejemplares similares
-
Case Report: A novel KNCH2 variant-induced fetal heart block and the advantages of fetal genomic sequencing in prenatal long-term dexamethasone exposure
por: Huang, Huiping, et al.
Publicado: (2022) -
Case Report: Prenatal Diagnosis and Treatment of Fetal Autoimmune-Associated First-Degree Atrioventricular Block: First Report From China
por: Tang, Changqing, et al.
Publicado: (2021) -
Successful Prevention of Fetal Autoimmune-Mediated Heart Block by Combined Therapies With Hydroxychloroquine and Intravenous Immunoglobulin: A Case Report
por: Zhao, Li, et al.
Publicado: (2021) -
Prenatal Management Strategy for Immune-Associated Congenital Heart Block in Fetuses
por: Liao, Hongyu, et al.
Publicado: (2021) -
The molecular mechanisms in prenatal drug exposure-induced fetal programmed adult cardiovascular disease
por: Wu, Ting, et al.
Publicado: (2023)